Literature DB >> 11733436

Why should primary care physicians know about the genetics of dementia?

L E Pinsky1, W Burke, T D Bird.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11733436      PMCID： PMC1275977          DOI： 10.1136/ewjm.175.6.412

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  34 in total

1.  Genetic discrimination and health insurance: an urgent need for reform.

Authors:  K L Hudson; K H Rothenberg; L B Andrews; M J Kahn; F S Collins
Journal:  Science       Date:  1995-10-20       Impact factor: 47.728

2.  Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Alzheimer's disease.

Authors:  A D Roses
Journal:  Ann Neurol       Date:  1995-07       Impact factor: 10.422

3.  The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial. The Donepezil Study Group.

Authors:  S L Rogers; L T Friedhoff
Journal:  Dementia       Date:  1996 Nov-Dec

4.  Alzheimer's disease: identical phenotype of familial and non-familial cases.

Authors:  M Haupt; A Kurz; S Pollmann; B Romero
Journal:  J Neurol       Date:  1992-05       Impact factor: 4.849

Review 5.  Statement on use of apolipoprotein E testing for Alzheimer disease. American College of Medical Genetics/American Society of Human Genetics Working Group on ApoE and Alzheimer disease.

Authors: 
Journal:  JAMA       Date:  1995 Nov 22-29       Impact factor: 56.272

6.  Comparison of the severity of neuropathologic changes in familial and sporadic Alzheimer's disease.

Authors:  D Nochlin; G van Belle; T D Bird; S M Sumi
Journal:  Alzheimer Dis Assoc Disord       Date:  1993       Impact factor: 2.703

7.  Genetic discrimination: perspectives of consumers.

Authors:  E V Lapham; C Kozma; J O Weiss
Journal:  Science       Date:  1996-10-25       Impact factor: 47.728

8.  Influence of apolipoprotein E genotype on the transmission of Alzheimer disease in a community-based sample.

Authors:  G Jarvik; E B Larson; K Goddard; G D Schellenberg; E M Wijsman
Journal:  Am J Hum Genet       Date:  1996-01       Impact factor: 11.025

Review 9.  Apolipoprotein E and Alzheimer's disease: the implications of progress in molecular medicine.

Authors:  R Mayeux; N Schupf
Journal:  Am J Public Health       Date:  1995-09       Impact factor: 9.308

10.  Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease.

Authors:  C M van Duijn; P de Knijff; M Cruts; A Wehnert; L M Havekes; A Hofman; C Van Broeckhoven
Journal:  Nat Genet       Date:  1994-05       Impact factor: 38.330
View more
  1 in total

Review 1.  Alzheimer's disease: epidemiology, genetics, and beyond.

Authors:  Xiao-Ping Wang; Hong-Liu Ding
Journal:  Neurosci Bull       Date:  2008-04       Impact factor: 5.203
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.